Results 241 to 250 of about 226,588 (381)

Vulnerability of marine megafauna to global at‐sea anthropogenic threats

open access: yesConservation Biology, Volume 40, Issue 1, February 2026.
Abstract Marine megafauna species are affected by a wide range of anthropogenic threats. To evaluate the risk of such threats, species’ vulnerability to each threat must first be determined. We build on the existing threats classification scheme and ranking system of the International Union for Conservation of Nature (IUCN) Red List of Threatened ...
Michelle VanCompernolle   +309 more
wiley   +1 more source

Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1998
A. Dierich   +6 more
semanticscholar   +1 more source

Pharmacological intervention: Challenges and promising outcomes for fat loss and preservation of lean body mass in the treatment of overweight and type 2 diabetes

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 803-816, February 2026.
Abstract Treatment with GLP‐1 receptor agonists (GLP‐1 RAs) is effective in reducing body weight in individuals with overweight and type 2 diabetes (T2D). However, measurements indicate that a considerable portion of the weight loss derives from fat‐free mass (FFM), including skeletal muscle, which may compromise metabolic health and physical function.
Viktor Aimelet, Jens Juul Holst
wiley   +1 more source

The Characteristics and Expression of <i>RBX1</i> Gene Involved in Ovarian Development of <i>Scylla paramamosain</i>. [PDF]

open access: yesInt J Mol Sci
Zhang F   +10 more
europepmc   +1 more source

The Relationship of Basal LH/FSH Ratio and Basal Estradiol Level with Oocyte and Embryo Quality in Cases with Polycystic Ovary Syndrome

open access: bronze
Aslı Akdöner   +10 more
openalex   +2 more sources

Safety and efficacy of the therapy with CD4 + CD25highCD127‐T regulatory cells: When paediatric patient becomes adult

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1392-1402, February 2026.
Abstract Aim CD4 + CD25highCD127‐T regulatory cells (Tregs) remain a drug candidate for immunotherapy of type 1 diabetes. We completed three trials testing Tregs in recently diagnosed type 1 diabetes children. Here, we looked for long‐term safety and efficacy aspects important in the authorisation of this therapy.
Marta Bandura   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy